John G Kuhn

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Paul S Mischel, Steve Horvath, Timothy F Cloughesy, 2012, Cancer discovery.

Toward precision medicine in glioblastoma: the promise and the challenges.

Timothy C Ryken, Timothy F Cloughesy, Annette M Molinaro, 2015, Neuro-oncology.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.

Michael R Savona, Michael S Weiss, I. Flinn, 2018, The Lancet. Oncology.